Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics

Launched by FIRST AFFILIATED HOSPITAL XI'AN JIAOTONG UNIVERSITY · Aug 14, 2023

Keywords

ClinConnect Summary

This clinical trial is focused on understanding heart and brain diseases better, particularly conditions like coronary artery disease, arrhythmias, and strokes. Researchers aim to gather information and samples from patients with these diseases to explore the underlying causes and improve treatment options. By using advanced technology that analyzes biological data, the study hopes to create better ways to predict how patients will respond to treatment and tailor care to individual needs.

To participate in this trial, patients must be between 3 and 80 years old and have a diagnosed cardiovascular or cerebrovascular condition, such as heart valve disease or high blood pressure. If you join the study, you will be regularly monitored and followed up on, which will help the researchers gather valuable information. It's important to note that pregnant or breastfeeding women, as well as those unable to provide consent, are not eligible to participate. This trial is currently recruiting participants, and your involvement could contribute to important advancements in treating heart and brain diseases.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients who are regularly visited and followed up in the appropriate patient; department.
• * All patients met at least one of the following diagnostic criteria for cardiovascular and cerebrovascular diseases:
• • coronary artery disease group;
• • arrhythmia group;
• • heart valve disease group;
• • aortic dissection group;
• • cardiac masses group;
• • myocarditis group;
• • hypertension group;
• • cardiomyopathy group;
• • structural heart disease group;
• • ischemic cerebrovascular disease group;
• • hemorrhagic cerebrovascular disease group;
• • intracranial space occupying lesion group.
• Exclusion Criteria:
• • Age \<3 years or \>80 years old;
• • Pregnant and lactating women;
• • The patient declined to provide informed consent to participate in the study;
• • None of the above was met, but the patient was temporarily unable to sign the informed consent form due to coma and other reasons, and no legal representative signed it instead. Depending on the patient's condition, the patient may not be able to regain consciousness and sign the informed consent form.